Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid Tumors
Replimune Inc.
Replimune Inc.
Shanghai Juncell Therapeutics
Indiana University
Celldex Therapeutics
National Cancer Institute (NCI)
Jiangsu HengRui Medicine Co., Ltd.
Silverback Therapeutics
Virginia Commonwealth University
IGF Oncology, LLC
University of Illinois at Chicago
Jules Bordet Institute
Poniard Pharmaceuticals
Poniard Pharmaceuticals
Pharmacyclics LLC.